Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Anti-Cancer Drugs|February 15, 2014
Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMBAaron T Wecksler, Sung Hee Hwang, Hiromi I Wettersten, et al.Journal of Cardiovascular Pharmacology|May 17, 2013
Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertensionArzu Ulu, Todd R Harris, Christophe Morisseau, et al.Kidney International|May 27, 2017
Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney diseaseVicki J Hwang, Xia Zhou, Xiaonan Chen, et al.Kidney360|February 28, 2022
Anti-Cancer Activity of PAK4/NAMPT Inhibitor and Programmed Cell Death Protein-1 Antibody in Kidney CancerJosephine F Trott, Omran Abu Aboud, Bridget McLaughlin, et al.American Journal of Physiology. Renal Physiology|October 4, 2018
Arginine reprogramming in ADPKD results in arginine-dependent cystogenesisJosephine F Trott, Vicki J Hwang, Tatsuto Ishimaru, et al.Plos One|December 18, 2015
Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid SupplementationClaire C Berthelot, Shizuo George Kamita, Romina Sacchi, et al.Oncotarget|January 27, 2018
The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferationCristina Bianchi, Chiara Meregalli, Silvia Bombelli, et al.Oncotarget|August 31, 2016
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancerJosephine F Trott, Jeffrey Kim, Omran Abu Aboud, et al.Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasisGuodong Zhang, Dipak Panigrahy, Sung Hee Hwang, et al.Oncotarget|October 24, 2018
XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignanciesHan Bit Baek, Alan P Lombard, Stephen J Libertini, et al.Pageof 10